4.4 Article

Determination of dose enhancement caused by gold-nanoparticles irradiated with proton, X-rays (kV and MV) and electron beams, using alanine/EPR dosimeters

期刊

RADIATION MEASUREMENTS
卷 82, 期 -, 页码 122-128

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.radmeas.2015.09.008

关键词

Proton; Dose enhancement; EPR dosimetry; Alanine; Gold-nanoparticles

资金

  1. school of Medical Sciences at RMIT University
  2. ARC

向作者/读者索取更多资源

The main aims of this research was to employ alanine doped with gold-nanoparticles AuNPs to determine the levels of dose enhancement caused by these particles when irradiated with proton beams, low and high energy X-rays and electrons. DL-alanine was impregnated with 5 nm gold-nanoparticles (3% by weight) and added as a uniform layer within a wax pellet of dimensions 10 x 5 x 5 mm. Control pellets, containing DL-Alanine were also produced, and placed within a phantom, and exposed to various types of radiations: low energy (kV ranges) X-rays were obtained from a superficial machine, high energy (MV) X-rays and electrons derived from a linear accelerator, and protons were produced by the Hyogo Ion Beam Centre in Japan. Nominal doses received ranged from 2 to 20 Gy (within clinical range). The Electron Paramagnetic Resonance (EPR) spectra of the irradiated samples were recorded on a BRUKER Elexsys 9.5 MHz. The dose enhancement caused by gold nanoparticles for 80 kV x-rays was found to be more than 60% at about 5 Gy. Smaller dose enhancements (under the same measurement conditions) were observed for megavoltage x-ray beams (up to 10%). Dose enhancement caused by charged particles indicated minimal values for 6 MeV electrons (approximately 5%) whilst less than that is obtained with protons of 150 MeV. The proton results validate the latest simulation results based on Monte Carlo calculations but the dose enhancement is significantly less than that reported in cell and animal model systems, (about 20%). We attribute this difference to the fact that alanine only measures the levels of free radicals generated by the inclusion of nanoparticles and not the redox type radicals (such as reactive oxygen species) generated from aqueous media in cells. Dose enhancement caused by 5 nm gold-nanoparticles with radiotherapy type proton beams has been found to be less than 5% as determined when using alanine/wax as both a phantom and dosimeter. This agrees well with the latest Monte Carlo simulation results for similar sized gold-nanoparticles. Furthermore, our results for both low and high energy x-rays are validated against published data for in vitro studies. (C) 2015 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Multidisciplinary Sciences

Targeting LOX-1 in atherosclerosis and vasculopathy: current knowledge and future perspectives

Kunming Tian, Sayoko Ogura, Peter J. Little, Suo-wen Xu, Tatsuya Sawamura

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2019)

Article Cell Biology

Individual Smad2 linker region phosphorylation sites determine the expression of proteoglycan and glycosaminoglycan synthesizing genes

Danielle Kamato, Micah Burch, Ying Zhou, Raafat Mohamed, Jennifer L. Stow, Narin Osman, Wenhua Zheng, Peter J. Little

CELLULAR SIGNALLING (2019)

Review Pharmacology & Pharmacy

Danhong injection in cardiovascular and cerebrovascular diseases: Pharmacological actions, molecular mechanisms, and therapeutic potential

Xiaojun Feng, Yi Li, Yanan Wang, Lingli Li, Peter J. Little, Suo-wen Xu, Sheng Liu

PHARMACOLOGICAL RESEARCH (2019)

Article Cell Biology

Transforming growth factor-1 mediated CHST11 and CHSY1 mRNA expression is ROS dependent in vascular smooth muscle cells

Raafat Mohamed, Parisa Dayati, Reyhaneh Niayesh Mehr, Danielle Kamato, Faezeh Seif, Hossein Babaahmadi-Rezaei, Peter J. Little

JOURNAL OF CELL COMMUNICATION AND SIGNALING (2019)

Review Pharmacology & Pharmacy

Treatment of atherosclerotic plaque: perspectives on theranostics

Yicong Zhang, Aayushi Koradia, Danielle Kamato, Amirali Popat, Peter J. Little, Hang T. Ta

JOURNAL OF PHARMACY AND PHARMACOLOGY (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Evaluation of the IAEA-TRS 483 protocol for the dosimetry of small fields (square and stereotactic cones) using multiple detectors

Clare L. Smith, Atousa Montesari, Christopher P. Oliver, Duncan J. Butler

JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS (2020)

Review Medicine, Research & Experimental

Smad2 linker region phosphorylation is an autonomous cell signalling pathway: Implications for multiple disease pathologies

Danielle Kamato, Peter J. Little

BIOMEDICINE & PHARMACOTHERAPY (2020)

Article Cell Biology

Glutamate Attenuates the Survival Property of IGFR through NR2B Containing N-Methyl-D-aspartate Receptors in Cortical Neurons

Xia Zhao, Chao Han, Zhiwen Zeng, Linlin Liu, Haitao Wang, Jiangping Xu, Zhong-Ping Feng, Peter J. Little, Remi Quirion, Wenhua Zheng

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Samarium doped titanium dioxide nanoparticles as theranostic agents in radiation therapy

Masao Nakayama, Clare L. Smith, Bryce N. Feltis, Terrence J. Piva, Farnaz Tabatabaie, Peter D. Harty, Frank M. Gagliardi, Kirsten Platts, Sarah Otto, Anton Blencowe, Kenta Morita, Moshi Geso

PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS (2020)

Article Biochemistry & Molecular Biology

Lysophosphatidic acid receptor 5 transactivation of TGFBR1 stimulates the mRNA expression of proteoglycan synthesizing genes XYLT1 and CHST3

Ying Zhou, Peter J. Little, Yingnan Cao, Hang T. Ta, Danielle Kamato

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2020)

Article Biochemistry & Molecular Biology

Curcumin Inhibits Lysophosphatidic Acid Mediated MCP-1 Expression via Blocking ROCK Signalling

Ying Zhou, Peter J. Little, Suowen Xu, Danielle Kamato

Summary: Curcumin, a natural compound widely used in Asian countries, has anti-inflammatory and anti-oxidative properties. Researchers have found that curcumin can prevent atherosclerosis by blocking ROCK signaling pathway.

MOLECULES (2021)

Review Pharmacology & Pharmacy

Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies

Suowen Xu, Iqra Ilyas, Peter J. Little, Hong Li, Danielle Kamato, Xueying Zheng, Sihui Luo, Zhuoming Li, Peiqing Liu, Jihong Han, Ian C. Harding, Eno E. Ebong, Scott J. Cameron, Alastair G. Stewart, Jianping Weng

Summary: The endothelium, a cellular monolayer lining the blood vessel wall, plays a critical role in maintaining multiorgan health and homeostasis. Dysfunction of the vascular endothelium is associated with various diseases and is implicated in severe coronavirus disease 2019. Therapeutic approaches targeting endothelial dysfunction may have potential for treatment of cardiovascular and many other diseases.

PHARMACOLOGICAL REVIEWS (2021)

Review Biochemistry & Molecular Biology

Non-Mouse Models of Atherosclerosis: Approaches to Exploring the Translational Potential of New Therapies

Danielle Kamato, Iqra Ilyas, Suowen Xu, Peter J. Little

Summary: Cardiovascular disease, primarily caused by atherosclerosis, is the leading cause of disease-related mortality worldwide. Current therapeutic agents have limited efficacy in lowering plasma lipid levels and reducing deaths from cardiovascular disease. Suitable animal models that accurately reproduce human atherosclerosis are essential for pre-clinical research on novel cardiovascular drugs.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Biochemistry & Molecular Biology

Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies

Xiumei Wu, Mengyun Xu, Mengya Geng, Shuo Chen, Peter J. Little, Suowen Xu, Jianping Weng

Summary: The increasing prevalence of noncommunicable diseases (NCDs) has become a significant global public health burden. Metabolic diseases, the most common form of NCDs, have life-threatening cardiovascular complications and affect people of all ages. Protein posttranslational modification (PTM) greatly enhances the functional diversity of proteins and plays a crucial role in common metabolic diseases such as diabetes, obesity, and fatty liver diseases. Understanding the mechanisms of PTMs in metabolic diseases will provide new insights for therapeutic intervention and improvement of therapies.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2023)

Article Biochemistry & Molecular Biology

Artemisinin inhibits glycosaminoglycan chain synthesizing gene expression but not proliferation of human vascular smooth muscle cells

Ying Zhou, Hirushi Kumarapperuma, Salifya Sichone, Zheng Jie Chia, Peter J. Little, Suowen Xu, Danielle Kamato

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

暂无数据